Jeff Yass’s Insight Molecular Diagnostics IMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMDX
AIC
Jeff Yass's IMDX Position: Q3 2026 in Review
Jeff Yass opened a new position in Insight Molecular Diagnostics (IMDX) in Q3 2026: 44,042 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #12181 among its holdings. This is a return to the name: Jeff Yass previously reported a position in IMDX as recently as Q1 2026.
Jeff Yass first reported a position in IMDX in Q1 2017 and has held it in 20 quarters since. The position peaked at $543K in Q4 2025. 44 funds tracked by Wall St. Rank hold IMDX as of Q3 2026.
- Jeff Yass held 44,042 shares of Insight Molecular Diagnostics worth $158K as of Q3 2026.
- Insight Molecular Diagnostics was a new Jeff Yass position in Q3 2026.
- Insight Molecular Diagnostics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12181 holding.
- Jeff Yass first reported a position in Insight Molecular Diagnostics in Q1 2017 and has held it in 20 quarters since.
- Jeff Yass's Insight Molecular Diagnostics position peaked at $543K in Q4 2025.
- 44 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.